Retatrutide (10mg | 30mg | 50mg) from

Retatrutide | The Triple-Agonist "G3" Peptide

Retatrutide is the most potent metabolic research tool developed to date. As a first-in-class triple hormone receptor agonist, it targets GLP-1, GIP, and Glucagon receptors simultaneously. By integrating three distinct pathways, Retatrutide offers a synergistic approach to body composition and energy regulation that far surpasses earlier generations of peptide therapy.

The Triple-Pathway Mechanism

Retatrutide mimics three endogenous hormones to optimize metabolic efficiency:

• GLP-1 (Glucagon-Like Peptide-1): Enhances insulin secretion and signals early satiety to the brain.

• GIP (Glucose-Dependent Insulinotropic Polypeptide): Works in tandem with GLP-1 to improve lipid metabolism and reduce systemic inflammation.

• Glucagon Receptor: Uniquely increases thermogenesis (calorie burning) and specifically targets hepatic fat, accelerating the breakdown of stored lipids.

Fitness & Body Composition Benefits

In a research context, Retatrutide has demonstrated transformative potential for body optimization:

• Accelerated Lipolysis: By activating the glucagon receptor, it forces the body to utilize stored fat for energy more aggressively than single-agonist peptides.

• Metabolic Rate Enhancement: Unlike other GLP-1s that may lower energy levels, Retatrutide’s glucagon component helps maintain a higher basal metabolic rate (BMR).

• Preservation of Lean Mass: By achieving rapid fat loss through multiple pathways, researchers are studying its ability to reach target body fat percentages faster, potentially reducing the duration of "cutting" phases.

• Liver & Cardiovascular Health: Studies show a significant reduction in liver fat and improved lipid profiles, supporting overall athletic longevity.Retatrutide (LY3437943) | The Triple-Agonist "G3" Peptide

  Retatrutide is the most potent metabolic research tool developed to date. As a first-in-class triple hormone receptor agonist, it targets GLP-1, GIP, and Glucagon receptors simultaneously. By integrating three distinct pathways, Retatrutide offers a synergistic approach to body composition and energy regulation that far surpasses earlier generations of peptide therapy.

  The Triple-Pathway Mechanism

  Retatrutide mimics three endogenous hormones to optimize metabolic efficiency:

  • GLP-1 (Glucagon-Like Peptide-1): Enhances insulin secretion and signals early satiety to the brain.

  • GIP (Glucose-Dependent Insulinotropic Polypeptide): Works in tandem with GLP-1 to improve lipid metabolism and reduce systemic inflammation.

  • Glucagon Receptor: Uniquely increases thermogenesis (calorie burning) and specifically targets hepatic fat, accelerating the breakdown of stored lipids.

  Fitness & Body Composition Benefits

  In a research context, Retatrutide has demonstrated transformative potential for body optimization:

  • Accelerated Lipolysis: By activating the glucagon receptor, it forces the body to utilize stored fat for energy more aggressively than single-agonist peptides.

  • Metabolic Rate Enhancement: Unlike other GLP-1s that may lower energy levels, Retatrutide’s glucagon component helps maintain a higher basal metabolic rate (BMR).

  • Preservation of Lean Mass: By achieving rapid fat loss through multiple pathways, researchers are studying its ability to reach target body fat percentages faster, potentially reducing the duration of "cutting" phases.

  • Liver & Cardiovascular Health: Studies show a significant reduction in liver fat and improved lipid profiles, supporting overall athletic longevity.

  Technical Specifications

  • Sequence: 39-amino acid synthetic peptide.

  • Molecular Formula:

    $$C_{221}H_{342}N_{52}O_{68}$$

  • Purity: $>99\%$ (HPLC/MS verified).

  • Form: Lyophilized powder.

  • Storage: Stable at room temperature for short-term; store at -20°C for long-term stability.

In a research context, Retatrutide has demonstrated transformative potential for body optimization:

• Accelerated Lipolysis: By activating the glucagon receptor, it forces the body to utilize stored fat for energy more aggressively than single-agonist peptides.

• Metabolic Rate Enhancement: Unlike other GLP-1s that may lower energy levels, Retatrutide’s glucagon component helps maintain a higher basal metabolic rate (BMR).

• Preservation of Lean Mass: By achieving rapid fat loss through multiple pathways, researchers are studying its ability to reach target body fat percentages faster, potentially reducing the duration of "cutting" phases.

• Liver & Cardiovascular Health: Studies show a significant reduction in liver fat and improved lipid profiles, supporting overall athletic longevity.

Technical Specifications

• Sequence: 39-amino acid synthetic peptide.

• Storage: Stable at room temperature for short-term; store at -20°C for long-term stability.